Intervention
Blood tests
ClinicalTrials.gov intervention label
Clinical trials
13 shownManganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection FractionNCT06652763 · 2024-10-10
RECRUITINGNon-Invasive Malignancy Classifiers Using Blood-Biomarkers for Lung Nodule EvaluationNCT07623473 · 2024-05-22
RECRUITINGAutonomic Regulation of Blood Pressure in Premature and Early Menopausal WomenNCT04439370 · 2019-10-01
RECRUITINGPrevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes MellitusNCT03132129 · 2017-10-24
RECRUITINGScreening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes MellitusNCT04232293 · 2021-06-25
COMPLETEDCarbohydrates Under Target for Type 1 Diabetes ManagementNCT04758858 · 2021-03-01
WITHDRAWNEffect of Obesity on Immune Response to Pneumovax 23NCT02471014 · 2016-12-01
COMPLETEDEnergy Balance Following Islet TransplantationNCT03063229 · 2016-06-01
TERMINATEDTreatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223NCT03223727 · 2015-10-30
COMPLETEDLong Term Follow up for the Detection of Delayed Adverse Events in Cal-1 RecipientsNCT02390297 · 2015-04-01
ACTIVE_NOT_RECRUITINGThe University of Hong Kong Neurocognitive Disorder CohortNCT03275363 · 2014-09-01
UNKNOWNPulmonary Function, Chronic Obstructive Pulmonary Disease (COPD) Prevalence, and Systemic Inflammation in Chronic Heart Failure With or Without COPDNCT01429376 · 2009-10-01
COMPLETEDEffect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic PatientsNCT00159770 · 2001-11-01
COMPLETEDCommon conditions
Diabetes Mellitus, Type 22Type 1 Diabetes2Age-related Cognitive Decline1Alzheimer Dementia1Blood Pressure1Bone Metastases1Diabetic Cardiomyopathies1Heart Failure1Heart Failure With Preserved Ejection Fraction1HIV-1 Infection1Hypertension1Inflammation1Lung Cancer (Diagnosis)1Menopause1Menopause, Premature1Mild Cognitive Impairment1NAFLD1NASH1Neurocognitive Disorder1Nodule, Solitary Pulmonary1Obesity1Prostate Cancer Metastatic1Psychotic Disorders1Pulmonary Disease, Chronic Obstructive1Receipt of Cal-1 Modified Hematopoietic Cellular Products1
Leading sponsors
University of Leicester2Calimmune, Inc.1Herlev and Gentofte Hospital1Institut de Recherches Cliniques de Montreal1Nantes University Hospital1Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1Rijnstate Hospital1The Netherlands Cancer Institute1The University of Hong Kong1University of Edinburgh1University of Florida1University of Minnesota1
Trial status mix
COMPLETED5
RECRUITING4
ACTIVE_NOT_RECRUITING1
TERMINATED1
UNKNOWN1
WITHDRAWN1
Phase mix
NA4
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.